🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, prospective cohort study conducted across 9 tertiary...
Status
Completed
Location
Laiko General Hospital
Start Date
2024-06-01
Trial ID
NCT07299838
A single-centre Phase 1b study to assess the safety, tolerability, pharmaco...
Status
Completed
Location
Q-Pharm
Start Date
2018-04-23
Trial ID
NCT03542149
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This trial will look at a drug called SEA-CD70 with and without azacitidine...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-07
Trial ID
NCT04227847
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
This study will investigate whether GC1008, an antibody which neutralizes T...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00464321
500 pregnant patients with HBeAg-positive and HBV-DNA≥ 106copies /ml who wi...
Status
Unknown
Location
First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2015-03
Trial ID
NCT02719808
Treatments Being Tested
This study will be conducted to evaluate a Single-Dose Subcutaneous (SC) Ax...
Status
Completed
Location
Celerion, Inc
Start Date
2025-01-14
Trial ID
NCT06713590
Treatments Being Tested
A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-27
Trial ID
NCT03392961
Treatments Being Tested
This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE
Start Date
2020-07-17
Trial ID
NCT04561362
Treatments Being Tested